Prevalence of parosmia · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in taste · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease‐related quality of life · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Outcomes at end of treatment · adults with tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Impact of tinnitus on quality of life · adults with tinnitus
1 finding from 1 review
Serious adverse effects at end of treatment · adults with tinnitus
CBT showed no clear difference in serious adverse effects at end of treatment compared with no intervention/waiting list control (moderate certainty).
1 finding from 1 review
Depression at end of treatment · adults with tinnitus
1 finding from 1 review
Anxiety · adults with tinnitus
1 finding from 1 review
Health‐related quality of life · adults with tinnitus
1 finding from 1 review
Negatively biased interpretations of tinnitus · adults with tinnitus
1 finding from 1 review
Other adverse effects · adults with tinnitus
1 finding from 1 review
Adverse events: Dysphagia‐related complications Occurrence of dysphagia‐related complications: pneumonia, dehydration, mucositis and oral yeast infection · adults with advanced head and neck cancer
1 finding from 1 review
Adverse event: Weight loss (> 10%) Change in nutritional status reflected by a patient's weight at 6 weeks after treatment · adults with advanced head and neck cancer
It is very uncertain whether therapeutic swallowing exercises changes adverse event: Weight loss (> 10%) Change in nutritional status… compared with sham intervention (very low certainty).
1 finding from 1 review
Improvement in vertigo frequency · Ménière’s disease
It is very uncertain whether betahistine changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).
2 findings from 1 review
Vertigo (global score) at < 3 months · Ménière’s disease
1 finding from 1 review
Change in vertigo frequency · Ménière’s disease
2 findings from 1 review
Serious adverse events · Ménière’s disease
It is very uncertain whether betahistine changes serious adverse events compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Improvement in vertigo frequency · Ménière’s disease
It is very uncertain whether diuretic changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Change in vertigo frequency · Ménière’s disease
1 finding from 1 review
Improvement in vertigo · people with vestibular migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found